Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Report on fraud a bitter pill for Pfizer, GlaxoSmithKline
The Day, CT
Saturday, December 18, 2010 - 12:52pm
tags:
Pfizer, GSK, Eli Lilly, Schering Plough
Stason Pharma gets world-wide non-exclusive license to use Lonza's GS Gene Expression System
Pharmabiz
Saturday, December 18, 2010 - 12:48pm
tags:
Statson Pharma, Lonza, Tissue Necrosis Therapy, monoclonal antibodies
Indian Pharma Industry to Witness Double-Digit Growth
New Design World
Saturday, December 18, 2010 - 12:45pm
tags:
India
Drug Companies Stocks Underperfomed: AMGN, NVO, JNJ
Trader's Huddle
Saturday, December 18, 2010 - 12:44pm
tags:
Amgen, Novo Nordisk, JNJ
SmarTrend Detects Potential Break Out In Shares of Nymox Pharmaceutical (NYMX)
Benzinga
Saturday, December 18, 2010 - 12:43pm
tags:
Nymox, investors
How Cheap Is Bristol-Myers Squibb's Stock by the Numbers?
Motley Fool
Saturday, December 18, 2010 - 12:40pm
tags:
Bristol-Myers Squibb
AG: J&J must pay $52M in Pa. drug pricing dispute
Yahoo/AP
Saturday, December 18, 2010 - 12:39pm
tags:
JNJ, legal
Astrazeneca Tumbles On FDA Delay For Blood Thinner
Forbes
Saturday, December 18, 2010 - 12:38pm
tags:
AstraZeneca, blood thinners, Brilinta
Johnson & Johnson outsourced Rolaids to candymaker
CNN Money
Saturday, December 18, 2010 - 12:37pm
tags:
JNJ, Rolaids, recalls
Amgen Drug Meets Primary Endpoint
Yahoo/Zacks
Saturday, December 18, 2010 - 12:35pm
tags:
Xgeva, Amgen, prostate cancer, Zometa
Charles River's Business Outlook
Yahoo/Zacks
Saturday, December 18, 2010 - 12:26pm
tags:
Charles River Laboratories
Complete Genomics Reports Third Quarter Results
Globe NewsWire
Saturday, December 18, 2010 - 12:25pm
tags:
Complete Genomics, earnings
Director Of Equity Research At RBC Capital Markets Covers Phase III Data For Multiple New Drugs; Find Out The Stocks That Investors Should Look At
Yahoo/Wall Street Transcript
Saturday, December 18, 2010 - 12:24pm
tags:
Athenahealth, Abbott Laboratories, Beckman Coulter, Agilent, AstraZeneca, Provenge, Dendreon, Benlysta, Human Genome Sciences, Telaprevir, Vertex Pharmaceuticals
The Law Office of Abe Shainberg Launches an Investigation into the Possible Breaches of Fiduciary Duty by the Board of Cypress Bioscience, Inc. in Connection with the Sale of Company to Ramius V & O Acquisition, LLC– CYPB
Yahoo/BusinessWire
Saturday, December 18, 2010 - 12:20pm
tags:
Cypress Bioscience, Ramius, legal, lawsuits
InterMune surges on EU lung drug recommendation
Yahoo/AP
Saturday, December 18, 2010 - 12:18pm
tags:
InterMune, Esbriet, idiopathic pulmonary fibrosis
What 20 Years Of Pharma Fraud Has Wrought
Pharmalot
Friday, December 17, 2010 - 11:52am
tags:
settlements, pharma industry
Cephalon Mourns the Passing of Founder, Chairman and CEO, Frank Baldino Jr., Ph.D.
Yahoo
Friday, December 17, 2010 - 11:49am
tags:
Pharma CEOs, Cephalon
GSK signs deal to sell Parkinson’s drug
Bizjournals.com
Friday, December 17, 2010 - 11:39am
tags:
GSK, Parkinson's Disease, Impax
Pfizer Sets CEO Read’s Salary, Bonus at $4.29 Million
Bloomberg
Friday, December 17, 2010 - 11:38am
tags:
Ian Read, Pfizer, Pharma CEOs, executive pay
Celgene Raises Price Of Blood Cancer Drug Revlimid By 4.5%
WSJ Online
Friday, December 17, 2010 - 11:36am
tags:
Revlimid, Celgene

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.